Eosinophilic solid and cystic renal cell carcinoma: clinicopathological analysis and molecular characterization
10.3760/cma.j.issn.0529-5807.2019.11.002
- VernacularTitle: 嗜酸性实性和囊性肾细胞癌的临床和分子病理学特征
- Author:
Qiuyuan XIA
1
;
Xuan WANG
;
Xue WEI
;
Xiaotong WANG
;
Henghui MA
;
Zhenfeng LU
;
Qiu RAO
Author Information
1. Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China
- Publication Type:Journal Article
- Keywords:
Kidney neoplasms;
Immunohistochemistry;
Diagnosis, differential
- From:
Chinese Journal of Pathology
2019;48(11):840-845
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the clinicopathological features, immunohistochemical phenotype, molecular changes, differential diagnosis and prognosis of eosinophilic solid and cystic renal cell carcinoma (ESC RCC).
Methods:A total of 15 cases were selected from 2005 to 2019 at Nanjing Jinling Hospital,Nanjing University School of Medicine for clinicopathological and immunohistochemical analysis, 10 of which were subject to cancer-associated mutation analysis using targeted next-generation sequencing (NGS) panel. A literature review was also performed.
Results:The patients′ ages ranged from 15 to 68 years (mean, 33 years). The male-to-female ratio was 1.1∶1.0. During a mean follow-up of 22 months, none of the patients developed tumor recurrence, progression or metastasis. Histologically, the tumors typically demonstrated solid and cystic architectures and the neoplastic cells contained voluminous eosinophilic cytoplasm with prominent granular cytoplasmic stippling. Immunohistochemically, tumor cells in all cases were immunoreactive for CK20. Signal pathway related protein mTOR and S6 were positive in 14/15 and 6/15 cases, respectively. Cathepsin K, Melan A and HMB45 were at least focally positive in 12/15, 6/15 and 2/15 cases, respectively. CK7 and CD10 showed focal immunostain positivity in some cases, while TFE3, TFEB, CA9 and CD117 were negative in all cases. NGS demonstrated TSC1/TSC2 mutations in all tested cases (10/10).
Conclusions:ESC RCC is a rare tumor that tends to occur in young patients with an indolent behavior. Diagnosis can be established by its distinct clinical and histopathologic findings, immunohistochemical phenotype and molecular genetics. The tumor may be considered as a new subtype of RCC.
